The regulatory mechanisms of PD-L1 expression in bladder cancer have not yet been fully elucidated, and exploring these mechanisms is crucial for developing potential therapeutic strategies and improving immunotherapy efficacy. The gene discussed is CD274; the disease is urinary bladder cancer.